SOPHARMA AD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.02 BGN | +0.33% |
|
-0.66% | +5.24% |
| 29/02 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Chart calendar Sopharma AD
154ac30.Jp90kzvuXYQPvyASJUNrBx2v2GPrE0SYQ4zn5pY-nqA.f8UExF68cMhp6BlDdTJdQSjWqiSkWx2uNsiC1dR6reZjzjDiDok81T3SdQ~bdfebe1eaee053b309617d32465f0142
Upcoming events on Sopharma AD
Past events on Sopharma AD
| 22/04/2024 | March 2024 Sales and Revenue Release |
| 20/03/2024 | February 2024 Sales and Revenue Release |
| 29/02/2024 | Q4 2023 Earnings Release |
| 19/02/2024 | January 2024 Sales and Revenue Release |
| 23/01/2024 | December 2023 Sales and Revenue Release |
| 20/12/2023 | November 2023 Sales and Revenue Release |
| 29/11/2023 | Q3 2023 Earnings Release |
| 20/11/2023 | October 2023 Sales and Revenue Release |
| 20/10/2023 | September 2023 Sales and Revenue Release |
| 20/09/2023 | August 2023 Sales and Revenue Release |
| 29/08/2023 | Q2 2023 Earnings Release |
| 21/08/2023 | July 2023 Sales and Revenue Release |
| 20/07/2023 | June 2023 Sales and Revenue Release |
| 20/06/2023 | May 2023 Sales and Revenue Release |
| 02/06/2023 01:30 pm | Annual General Meeting |
| 30/05/2023 | Q1 2023 Earnings Call |
| 30/05/2023 | Q1 2023 Earnings Release |
| 22/05/2023 | April 2023 Sales and Revenue Release |
| 20/04/2023 | March 2023 Sales and Revenue Release |
| 20/03/2023 | February 2023 Sales and Revenue Release |
Past dividends on Sopharma AD
| 07/12/2023 | Interim Payment 0.9 BGN |
| 15/06/2023 | Annual 0.6 BGN |
| 08/10/2020 | Interim Payment 0.04 BGN |
| 18/06/2020 | Final Payment 0.07 BGN |
| 23/12/2019 | Interim Payment 0.05 BGN |
| 27/09/2018 | Interim Payment 0.05 BGN |
| 28/06/2018 | Annual 0.11 BGN |
| 15/06/2017 | Annual 0.1 BGN |
| 30/06/2016 | Annual 0.07 BGN |
| 03/07/2014 | Annual 0.07 BGN |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million BGN | Released Forecast Spread | 1 282 | 1 440 1 374 4.79% | 1 603 1 536 4.39% | 1 663 1 647 0.97% | 1 874 1 852 1.19% | 1 989 |
|
EBITDA Million BGN | Released Forecast Spread | 0,00 | 90,6 101 -10.47% | 0,00 0,00 - | 142 138 2.63% | 153 154 -0.45% | 143 |
|
EBIT Million BGN | Released Forecast Spread | 0,00 | 44,0 56,0 -21.43% | 63,1 53,6 17.81% | 89,6 86,0 4.15% | 0,00 0,00 - | 0,00 |
|
Earnings before Tax (EBT) Million BGN | Released Forecast Spread | 0,00 | 25,4 44,5 -42.95% | 0,00 0,00 - | 87,0 104 -16.64% | 0,00 0,00 - | 0,00 |
|
Net income Million BGN | Released Forecast Spread | 0,00 | 25,0 50,1 -50.15% | 91,4 36,6 149.75% | 72,6 88,6 -18.11% | 95,2 87,6 8.68% | 72,2 |
|
EPS BGN | Released Forecast Spread | 0,69 | 0,20 0,40 -50.25% | 0,00 0,00 - | 0,60 0,53 13.21% | 0,68 0,56 21.43% | 0,46 |
| Announcement Date | 29/04/20 | 01/03/21 | 31/01/22 | 01/03/23 | 29/02/24 | - |
More events
Past sector events for Sopharma AD
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SFA Stock
- Calendar Sopharma AD
